Bionor Rises Most in 15 Months on AIDS Drug Study:

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service27 times read : Adjust font size: Decrease font Enlarge font
image

Bionor Pharma ASA (BIONOR), the Norwegian developer of an experimental AIDS treatment, jumped the most in 15 months after it confirmed the injection fought HIV in a study and described plans to develop a drug it once gave up for dead. Bionor ...

Read this article...



Post your comment comment Comments (0 posted)

copyright